Prevalence of metabolic syndrome among hypertensive patients in Abuja Nigeria

Ethnicity and Disease

Volumn 22, Issue 1, 2012, Pages 1-4

  Ojji, Dike B ^a   Ajayi, Samuel O ^a   Mamven, Manmak H ^a   Alabi, Peter ^a  

^a UNIVERSITY OF ABUJA   (Nigeria)

Author keywords

Hypertension; Metabolic syndrome; Prevalence

Indexed keywords

ADULT; ARTICLE; BODY MASS; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NIGERIA; PREVALENCE;

FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS;

EID: 84861683831     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-2304. (Pubitemid 41242486)
2. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438. (Pubitemid 38133916)
3. Cheal LK, Abbasi F, Lamendola C, MC Laughlin T, Reaven MG, Ford SE. Relationship to insulin resistance of the adult treatment panel iii diagnostic criteria for identification of the metabolic syndrome. Diabetes. 2004;53:1195-1200. (Pubitemid 38569003)
4. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444-2449. (Pubitemid 39281399)
5. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709- 2716. (Pubitemid 35403784)
6. Takamiya T, Zaky WR, Edmundowics D, et al. World Health Organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel iii criteria in American men aged 40-49 years. Diabetes Care. 2004;27:2977-2979. (Pubitemid 39565070)
7. Scholze J, Alegria E, Ferri C, et al. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health. 2010;10:529.
8. Chih-Neng H, Ya-Chun C, Tzung-Dau W. Prevalence and characteristics of the metabolic syndrome in Chinese hypertensive patients: a hospital-based observation. Acta Cardiol Sin. 2005;21:89-97.
9. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemmi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999;245:163-174. (Pubitemid 29089113)
10. Sorkou EI, Al-Qallaf B, Al-Namash HA, Ben-Nakhi A, Al-Batish MM, Habiba SA. Prevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait. Med Princ Pract. 2004;13:39-42. (Pubitemid 37505814)
11. Ogah OS. Hypertension in sub-Saharan African Populations: the burden of hypertension in Nigeria. Ethn Dis. 2006;16(4):765.
12. Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis. 2007;193(1):70-76. (Pubitemid 46776712)
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care. 1997;20:1183-1197.
14. Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in native African type 2 diabetic patients. J Natl Med Assoc. 2005;97(4):557-563. (Pubitemid 40463586)
15. Alebiosu CO, Odusan BO. Metabolic syndrome in subjects with type 2 diabetes mellitus. J Natl Med Assoc. 2004;96(6):817-821. (Pubitemid 38745790)
16. Tuck ML, Sowers J, Dornfeld, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patient. N Engl J Med. 1981;304:930-933. (Pubitemid 11101080)